SEC Form 4 · accession 0001209191-18-028179

ACORDA THERAPEUTICS INC · ACOR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

May 2, 2018

Accepted (ET)

May 4, 2018 · 5:50 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001008848

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	May 2, 2018	M	10,000	$20.16	A	10,000	D
Common Stock^F1,F2	May 2, 2018	S	3,677	$23.4641	D	6,323	D
Common Stock^F1,F3	May 2, 2018	S	6,323	$23.8648	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Employee Stock Option^F1,F4	$20.16	May 2, 2018	M	10,000	D	—	May 21, 2018	Common Stock	10,000	0	D

F1Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised.
F2The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.7750 to $23.7000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $23.7750 to $24.0500 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4The shares subject to these options vested in installments and were fully vested on 05/21/2009.